The 5-day Summer School will focus on immunotherapy, vaccinology, microbiota interventions and drug development as intervention for infectious and hyperinflammatory diseases in humans and animals. The overall aim of the course is to give participants an understanding of immunomodulatory mechanisms induced by pathogens and commensals and how to exploit this for the development of interventions, like immunotherapy, host-directed personalized therapies and novel vaccines.

How to attend the Summer School?

This Summer School is suitable for (bio)medical Master students, PhD students, as well as early stage post-doctoral scientists who are interested in increasing their knowledge on human and animal infectious diseases, immunotherapy for inflammatory diseases, microbiota interventions and host-directed therapies against infectious diseases, clinical trials, and the industrial production of vaccines and antimicrobial therapies. Applicants are required to provide a CV, some background to the research they are engaged in, a motivation letter and letter of recommendation from their current supervisor.

Organisers

The LUMC Center of Infectious Diseases is collaborating with Edinburgh Infectious Diseases in the design and execution of the Summer School. We will combine elements on immune modulation, host-directed therapies, antimicrobial resistance, biodiversity and One Health, and vaccine development that utilize the strengths of both Leiden and Edinburgh. The course will also feature speakers from the Leiden Bioscience Park (e.g. the vaccine company Johnson & Johnson), as well as from the NCOH initiative on One Health, and a variety of other companies and institutes.

More information: Summer School Immune modulation in human and animal infections: Impact on health, disease and therapy – www.boerhaavecontinuingmedicaleducation.com